- Home
- Automated
- List of product information
- XYLONOR SOLUTION FOR OROMUCOSAL SPRAY 150MG/1.5MG PER G [SIN07224P]
XYLONOR SOLUTION FOR OROMUCOSAL SPRAY 150MG/1.5MG PER G [SIN07224P]
Active ingredients: XYLONOR SOLUTION FOR OROMUCOSAL SPRAY 150MG/1.5MG PER G
Last updated 26 October 2025
On this page
Product Info
XYLONOR SOLUTION FOR OROMUCOSAL SPRAY 150MG/1.5MG PER G
[SIN07224P]
Product information
Active Ingredient and Strength | CETRIMIDE - 0.15 G/100 G |
Dosage Form | SPRAY |
Manufacturer and Country | SEPTODONT - FRANCE |
Registration Number | SIN07224P |
Licence Holder | N.K. LUCK (S) PTE LTD |
Forensic Classification | PHARMACY ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | D04AB |
THERAPEUTIC INDICATIONS
This medicinal product is indicated for topical anaesthesia in adults, adolescents and children in the buccal cavity, before the following dental procedures:
infiltration anaesthesia,
fitting and adjusting of crowns and bridges abutment,
juxta-gingival and sub-gingival scaling.
Prevention of gagging during impression taking.
This medicine is indicated for the adults and the children and the teenagers aged from 6 to 18 years old.
POSOLOGY AND METHOD OF ADMINISTRATION
One pressure delivers approximately 10 mg of lidocaine.
The atomizer nozzle should be placed at about 2 to 4 cm from the area to be anesthetized.
Spray droplets of solution so as to cover an area of about 1 centimeter in diameter.
The application of one dose may be repeated onto 4 or 5 different areas of the oral mucosa during the same session.
In order to limit the nauseous reflex, pulverize one or several doses of solution towards the palate.
Do not exceed 20 pulverizations per session.
Paediatric population
XYLONOR is contraindicated for the children under 6 years of age, for the spray use, due to the risk of choking.
Elderly patients or patients with hepatic function disorders
When liver activity is reduced, the lowest dose leading to efficient anaesthesia shall be used when applied before anaesthetic injection.
Method and route of administration
Local use only. Buccal use.
Before using the atomizer, adjust the diffuser nozzle to the pump, then press vertically two or three times to prime the pump.
The solution should be applied to a previously dried mucous membrane.
The lowest dose leading to effective anaesthesia should be used.
Saliva aspiration and isolation with a dental cotton roll of the site treated with the local anaesthetic is required.
CONTRAINDICATIONS
This medicine should not be used in the following cases:
Children (age below 6 years old), because of a risk of choking. hypersensitivity to one of the ingredients, particularly to lidocaine (local anaesthesic) or to cetrimide (antiseptic).
hypersensitivity to any local anaesthetics.